| Literature DB >> 14633990 |
Koichiro Kuwahara1, Yoshihiko Saito, Makoto Takano, Yuji Arai, Shinji Yasuno, Yasuaki Nakagawa, Nobuki Takahashi, Yuichiro Adachi, Genzo Takemura, Minoru Horie, Yoshihiro Miyamoto, Takayuki Morisaki, Shinobu Kuratomi, Akinori Noma, Hisayoshi Fujiwara, Yasunao Yoshimasa, Hideyuki Kinoshita, Rika Kawakami, Ichiro Kishimoto, Michio Nakanishi, Satoru Usami, Yoshitomo Saito, Masaki Harada, Kazuwa Nakao.
Abstract
Reactivation of the fetal cardiac gene program is a characteristic feature of hypertrophied and failing hearts that correlates with impaired cardiac function and poor prognosis. However, the mechanism governing the reversible expression of fetal cardiac genes remains unresolved. Here we show that neuron-restrictive silencer factor (NRSF), a transcriptional repressor, selectively regulates expression of multiple fetal cardiac genes, including those for atrial natriuretic peptide, brain natriuretic peptide and alpha-skeletal actin, and plays a role in molecular pathways leading to the re-expression of those genes in ventricular myocytes. Moreover, transgenic mice expressing a dominant-negative mutant of NRSF in their hearts exhibit dilated cardiomyopathy, high susceptibility to arrhythmias and sudden death. We demonstrate that genes encoding two ion channels that carry the fetal cardiac currents I(f) and I(Ca,T), which are induced in these mice and are potentially responsible for both the cardiac dysfunction and the arrhythmogenesis, are regulated by NRSF. Our results indicate NRSF to be a key transcriptional regulator of the fetal cardiac gene program and suggest an important role for NRSF in maintaining normal cardiac structure and function.Entities:
Mesh:
Substances:
Year: 2003 PMID: 14633990 PMCID: PMC291842 DOI: 10.1093/emboj/cdg601
Source DB: PubMed Journal: EMBO J ISSN: 0261-4189 Impact factor: 11.598